Share Price and Basic Stock Data
Last Updated: November 7, 2025, 6:33 pm
| PEG Ratio | 1.39 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Balgopal Commercial Ltd operates in the Trading & Distributors industry, with its stock currently priced at ₹224 and a market capitalization of ₹426 Cr. The company recorded sales of ₹8.19 Cr for the financial year ending March 2023, which marked a slight increase from ₹8.00 Cr in the previous year. However, the company’s revenue trajectory has exhibited volatility, with quarterly sales fluctuating significantly. For instance, sales surged to ₹6.03 Cr in September 2023 and further to ₹8.92 Cr in December 2023, showcasing an impressive recovery from the lower figures of ₹1.00 Cr in June 2023. Nevertheless, the company is projected to experience a decline in sales, recording only ₹0.56 Cr for the financial year ending March 2025. This inconsistency highlights potential challenges in maintaining revenue stability, which may be of concern to investors. The company’s performance should be closely monitored to assess its ability to sustain growth in a competitive market.
Profitability and Efficiency Metrics
Balgopal Commercial Ltd’s profitability metrics present a mixed picture. The company reported a net profit of ₹0.17 Cr for the year ending March 2023, a significant decrease compared to ₹0.30 Cr in the previous year. The operating profit margin (OPM) stood at 2.32% for March 2023, indicating a marginal improvement from the previous year, although still below sector averages. The return on equity (ROE) was reported at 12.6%, which is relatively strong compared to sector norms, but the return on capital employed (ROCE) of 14.8% suggests that the company could improve its capital utilization. Additionally, the cash conversion cycle (CCC) stood at 217.90 days for the year ending March 2023, indicating inefficiencies in managing receivables and inventory. These profitability and efficiency metrics suggest that while Balgopal Commercial Ltd shows potential for profitability, operational efficiencies need to be addressed to enhance overall financial performance.
Balance Sheet Strength and Financial Ratios
The balance sheet of Balgopal Commercial Ltd reflects a cautious approach to leveraging, with total borrowings reported at ₹0.00 Cr, indicating a debt-free status. This is a notable strength, especially in the current economic climate where many companies face high debt burdens. The company’s reserves have increased significantly to ₹37.65 Cr as of March 2025, up from negative reserves in earlier years, showcasing a turnaround in its financial health. The price-to-book value (P/BV) ratio stood at 5.48x, suggesting that the stock may be overvalued compared to its book value. Additionally, the current ratio of 3.40 indicates a strong liquidity position, which is favorable for meeting short-term obligations. However, the absence of interest coverage ratio (ICR) data raises concerns about the company’s ability to manage any unforeseen financial obligations. Overall, while the balance sheet exhibits strength, the high P/BV ratio and lack of debt management metrics warrant careful consideration.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Balgopal Commercial Ltd reveals a significant shift in promoter stakes, which rose to 45.42% by June 2025, up from just 6.31% in September 2022. This dramatic increase indicates a growing confidence among promoters in the company’s future prospects, potentially reassuring investors. Conversely, public shareholding has decreased from 93.69% in September 2022 to 54.56% in June 2025, reflecting a change in investor sentiment. The total number of shareholders has also seen a consistent rise, reaching 1,386 by June 2025, which may suggest an increasing interest from retail investors. However, the declining public stake could signal a cautious outlook from institutional investors or a shift towards strategic consolidation among existing shareholders. This evolving shareholding structure may impact market perceptions and investor confidence moving forward.
Outlook, Risks, and Final Insight
Balgopal Commercial Ltd faces both opportunities and challenges as it navigates its operational landscape. The company’s debt-free status and increasing reserves are significant strengths that can support future growth initiatives. However, the volatility in revenue and profitability metrics poses risks that could affect its long-term sustainability. Moreover, the high P/BV ratio may deter value-oriented investors, while the declining public shareholding could raise questions about broader market confidence. As Balgopal Commercial Ltd continues to adapt to market dynamics, it must focus on enhancing operational efficiencies and stabilizing revenue streams. Should the company successfully address these challenges, it may unlock potential for significant growth. Conversely, failure to do so could lead to a further decline in investor confidence and market performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balgopal Commercial Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 70.0 Cr. | 3.65 | 5.59/3.20 | 41.7 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 13.5 Cr. | 15.3 | 18.6/13.0 | 449 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
| Modella Woollens Ltd | 6.50 Cr. | 71.4 | 74.2/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 95.5 Cr. | 46.6 | 49.8/10.2 | 94.6 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 110 Cr. | 98.6 | 174/84.4 | 15.5 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 10,457.45 Cr | 169.73 | 138.32 | 117.71 | 0.25% | 15.44% | 8.88% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.17 | 3.93 | 2.01 | 1.08 | 1.00 | 6.03 | 8.92 | 1.09 | 0.05 | 0.33 | 0.18 | 0.00 | 0.00 |
| Expenses | 1.12 | 3.81 | 2.00 | 1.17 | 0.97 | 4.62 | 7.69 | 1.39 | 0.22 | 0.24 | 0.45 | 0.36 | 0.30 |
| Operating Profit | 0.05 | 0.12 | 0.01 | -0.09 | 0.03 | 1.41 | 1.23 | -0.30 | -0.17 | 0.09 | -0.27 | -0.36 | -0.30 |
| OPM % | 4.27% | 3.05% | 0.50% | -8.33% | 3.00% | 23.38% | 13.79% | -27.52% | -340.00% | 27.27% | -150.00% | ||
| Other Income | 0.04 | 1.84 | 1.87 | -3.81 | 2.07 | 2.74 | 2.74 | 4.23 | 4.69 | 7.93 | 0.17 | -4.65 | 2.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 1.96 | 1.88 | -3.90 | 2.10 | 4.15 | 3.97 | 3.93 | 4.52 | 8.02 | -0.10 | -5.01 | 2.04 |
| Tax % | -377.78% | 10.71% | 5.85% | -3.08% | 23.33% | 0.72% | 6.80% | 5.09% | 14.16% | 11.35% | 170.00% | -12.57% | 17.65% |
| Net Profit | 0.43 | 1.75 | 1.77 | -3.78 | 1.61 | 4.11 | 3.70 | 3.74 | 3.88 | 7.10 | -0.27 | -4.38 | 1.68 |
| EPS in Rs | 0.26 | 1.06 | 1.07 | -2.29 | 0.98 | 2.49 | 2.24 | 2.27 | 2.35 | 4.30 | -0.16 | -2.30 | 0.88 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balgopal Commercial Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Mar 2025) to 0.30 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Mar 2025) to -0.30 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 2.34 Cr.. The value appears strong and on an upward trend. It has increased from -4.65 Cr. (Mar 2025) to 2.34 Cr., marking an increase of 6.99 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.01 Cr. (Mar 2025) to 2.04 Cr., marking an increase of 7.05 Cr..
- For Tax %, as of Jun 2025, the value is 17.65%. The value appears to be increasing, which may not be favorable. It has increased from -12.57% (Mar 2025) to 17.65%, marking an increase of 30.22%.
- For Net Profit, as of Jun 2025, the value is 1.68 Cr.. The value appears strong and on an upward trend. It has increased from -4.38 Cr. (Mar 2025) to 1.68 Cr., marking an increase of 6.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.88. The value appears strong and on an upward trend. It has increased from -2.30 (Mar 2025) to 0.88, marking an increase of 3.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:49 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.81 | 3.81 | 2.60 | 4.57 | 14.80 | 16.40 | 9.61 | 5.36 | 8.00 | 8.19 | 17.05 | 0.56 | 0.51 |
| Expenses | 0.80 | 4.13 | 3.00 | 5.22 | 15.97 | 19.79 | 18.16 | 6.13 | 8.55 | 8.00 | 14.69 | 1.27 | 1.35 |
| Operating Profit | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -0.77 | -0.55 | 0.19 | 2.36 | -0.71 | -0.84 |
| OPM % | 1.23% | -8.40% | -15.38% | -14.22% | -7.91% | -20.67% | -88.97% | -14.37% | -6.88% | 2.32% | 13.84% | -126.79% | -164.71% |
| Other Income | 0.00 | 0.40 | 0.45 | 0.70 | 0.82 | 1.29 | 1.57 | 7.52 | 0.92 | -0.05 | 11.79 | 8.14 | 5.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.08 | 0.05 | 0.05 | -0.35 | -2.10 | -6.98 | 6.75 | 0.37 | 0.04 | 14.15 | 7.43 | 4.95 |
| Tax % | 0.00% | 25.00% | 40.00% | 20.00% | -8.57% | 6.19% | -8.17% | 14.52% | 18.92% | -350.00% | 7.00% | 14.67% | |
| Net Profit | 0.00 | 0.06 | 0.03 | 0.05 | -0.32 | -2.24 | -6.42 | 5.77 | 0.30 | 0.17 | 13.17 | 6.34 | 4.13 |
| EPS in Rs | 0.00 | 0.04 | 0.02 | 0.03 | -0.19 | -1.36 | -3.89 | 3.49 | 0.18 | 0.10 | 7.98 | 3.34 | 2.72 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 66.67% | -740.00% | -600.00% | -186.61% | 189.88% | -94.80% | -43.33% | 7647.06% | -51.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 116.67% | -806.67% | 140.00% | 413.39% | 376.48% | -284.68% | 51.47% | 7690.39% | -7698.92% |
Balgopal Commercial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -43% |
| 3 Years: | -59% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 24% |
| 3 Years: | 185% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 137% |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: October 10, 2025, 3:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 19.01 |
| Reserves | 17.75 | 1.54 | 1.57 | 1.61 | 1.29 | -0.95 | -7.36 | -1.59 | -1.27 | -1.10 | 12.07 | 37.65 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 4.24 | 0.02 | 0.46 | 0.47 | 0.11 | 0.39 | 1.35 | 3.53 | 2.23 | 6.17 | 7.81 |
| Total Liabilities | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.42 | 2.40 | 5.79 | 7.42 | 3.60 | 4.28 | 4.48 | 11.44 | 16.89 | 7.28 | 21.09 | 40.03 |
| Other Assets | 10.57 | 19.89 | 12.31 | 11.16 | 14.67 | 11.39 | 5.06 | 5.08 | 1.88 | 10.36 | 13.66 | 24.44 |
| Total Assets | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
Below is a detailed analysis of the balance sheet data for Balgopal Commercial Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 19.01 Cr.. The value appears strong and on an upward trend. It has increased from 16.51 Cr. (Mar 2024) to 19.01 Cr., marking an increase of 2.50 Cr..
- For Reserves, as of Mar 2025, the value is 37.65 Cr.. The value appears strong and on an upward trend. It has increased from 12.07 Cr. (Mar 2024) to 37.65 Cr., marking an increase of 25.58 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.17 Cr. (Mar 2024) to 7.81 Cr., marking an increase of 1.64 Cr..
- For Total Liabilities, as of Mar 2025, the value is 64.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 40.03 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2024) to 40.03 Cr., marking an increase of 18.94 Cr..
- For Other Assets, as of Mar 2025, the value is 24.44 Cr.. The value appears strong and on an upward trend. It has increased from 13.66 Cr. (Mar 2024) to 24.44 Cr., marking an increase of 10.78 Cr..
- For Total Assets, as of Mar 2025, the value is 64.47 Cr.. The value appears strong and on an upward trend. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
Notably, the Reserves (37.65 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -1.02 | -0.55 | 0.19 | 2.36 | -0.71 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 233.75 | 4.21 | 112.61 | 195.57 | 107.94 | 109.01 | 121.89 | 15.06 | 25.85 | 0.00 | 0.00 |
| Inventory Days | 2,737.50 | 780.21 | 1,056.29 | 411.08 | 114.63 | 61.12 | 0.00 | 47.74 | 68.23 | 280.44 | 14.79 | |
| Days Payable | 0.00 | 407.49 | 0.00 | 32.92 | 11.15 | 0.00 | 46.27 | 97.68 | 88.38 | 0.00 | ||
| Cash Conversion Cycle | 3,102.50 | 606.48 | 1,060.50 | 490.78 | 299.04 | 169.06 | 109.01 | 123.36 | -14.39 | 217.90 | 14.79 | 0.00 |
| Working Capital Days | 4,763.02 | 1,491.61 | 1,715.50 | 852.20 | 349.22 | 251.94 | 158.76 | 264.90 | -53.84 | 365.45 | 160.34 | 6,537.41 |
| ROCE % | 0.06% | 0.44% | 0.28% | 0.28% | -1.11% | -12.59% | -56.50% | 55.51% | -1.97% | -16.64% | 17.50% | 14.81% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 15 | Mar 14 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.70 | 0.04 | 0.12 |
| Diluted EPS (Rs.) | 3.52 | 0.04 | 0.12 |
| Cash EPS (Rs.) | 3.31 | 0.03 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Revenue From Operations / Share (Rs.) | 0.29 | 2.56 | 33.95 |
| PBDIT / Share (Rs.) | 3.88 | 0.04 | 0.22 |
| PBIT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| PBT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| Net Profit / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| NP After MI And SOA / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| PBDIT Margin (%) | 1320.40 | 1.84 | 0.66 |
| PBIT Margin (%) | 1320.40 | 1.84 | 0.56 |
| PBT Margin (%) | 1320.40 | 1.84 | 0.56 |
| Net Profit Margin (%) | 1125.53 | 1.39 | 0.34 |
| NP After MI And SOA Margin (%) | 1125.53 | 1.39 | 0.34 |
| Return on Networth / Equity (%) | 11.12 | 0.32 | 0.01 |
| Return on Capital Employeed (%) | 12.50 | 0.42 | 0.02 |
| Return On Assets (%) | 9.49 | 0.26 | 0.01 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.00 | 0.20 | 0.00 |
| Current Ratio (X) | 3.40 | 4.69 | 3112.46 |
| Quick Ratio (X) | 1.66 | 2.79 | 1349.68 |
| Enterprise Value (Cr.) | 308.25 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 551.24 | 0.00 | 0.00 |
| EV / EBITDA (X) | 41.75 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 554.80 | 0.00 | 0.00 |
| Price / BV (X) | 5.48 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 555.10 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.00 | 0.00 |
After reviewing the key financial ratios for Balgopal Commercial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.70, marking an increase of 3.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.52, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.29. It has decreased from 2.56 (Mar 15) to 0.29, marking a decrease of 2.27.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For PBDIT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBIT Margin (%), as of Mar 25, the value is 1,320.40. This value exceeds the healthy maximum of 20. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For Net Profit Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 10. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 20. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has increased from 0.32 (Mar 15) to 11.12, marking an increase of 10.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 0.42 (Mar 15) to 12.50, marking an increase of 12.08.
- For Return On Assets (%), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 0.26 (Mar 15) to 9.49, marking an increase of 9.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.20 (Mar 15) to 0.00, marking a decrease of 0.20.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 15) to 3.40, marking a decrease of 1.29.
- For Quick Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.79 (Mar 15) to 1.66, marking a decrease of 1.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 308.25. It has increased from 0.00 (Mar 15) to 308.25, marking an increase of 308.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 551.24. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 551.24, marking an increase of 551.24.
- For EV / EBITDA (X), as of Mar 25, the value is 41.75. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 15) to 41.75, marking an increase of 41.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 554.80. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 554.80, marking an increase of 554.80.
- For Price / BV (X), as of Mar 25, the value is 5.48. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 5.48, marking an increase of 5.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 555.10. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 555.10, marking an increase of 555.10.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balgopal Commercial Ltd:
- Net Profit Margin: 1125.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.5% (Industry Average ROCE: 15.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.12% (Industry Average ROE: 8.88%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 100 (Industry average Stock P/E: 138.32)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1125.53%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | Flat No. B-002, Dreamax Vega, Upadhyay Compound, Pump House, Mumbai Maharashtra 400093 | info@bcommercial.org http://www.bcommercial.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Laltaprasad Yadav | Managing Director |
| Mr. Yash Saraogi | Non Executive Director |
| Mrs. Shrena Kalpesh Shah | Ind. Non-Executive Director |
| Ms. Shailesh Becharbhai Patel | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Balgopal Commercial Ltd?
Balgopal Commercial Ltd's intrinsic value (as of 08 November 2025) is 306.39 which is 40.55% higher the current market price of 218.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 415 Cr. market cap, FY2025-2026 high/low of 273/52.8, reserves of ₹37.65 Cr, and liabilities of 64.47 Cr.
What is the Market Cap of Balgopal Commercial Ltd?
The Market Cap of Balgopal Commercial Ltd is 415 Cr..
What is the current Stock Price of Balgopal Commercial Ltd as on 08 November 2025?
The current stock price of Balgopal Commercial Ltd as on 08 November 2025 is 218.
What is the High / Low of Balgopal Commercial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balgopal Commercial Ltd stocks is 273/52.8.
What is the Stock P/E of Balgopal Commercial Ltd?
The Stock P/E of Balgopal Commercial Ltd is 100.
What is the Book Value of Balgopal Commercial Ltd?
The Book Value of Balgopal Commercial Ltd is 29.8.
What is the Dividend Yield of Balgopal Commercial Ltd?
The Dividend Yield of Balgopal Commercial Ltd is 0.00 %.
What is the ROCE of Balgopal Commercial Ltd?
The ROCE of Balgopal Commercial Ltd is 14.8 %.
What is the ROE of Balgopal Commercial Ltd?
The ROE of Balgopal Commercial Ltd is 12.6 %.
What is the Face Value of Balgopal Commercial Ltd?
The Face Value of Balgopal Commercial Ltd is 10.0.